{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:24:38Z","timestamp":1787030678905,"version":"build-2736575974"},"reference-count":55,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2018.8837","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T05:04:31Z","timestamp":1527656671000},"source":"Crossref","is-referenced-by-count":9,"title":["The dog as an animal model for bladder and urethral urothelial carcinoma: Comparative epidemiology and histology"],"prefix":"10.3892","author":[{"given":"Simone","family":"de Brot","sequence":"first","affiliation":[{"name":"School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, LE12 5RD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Robinson","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weill Cornell Medical College, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Scase","sequence":"additional","affiliation":[{"name":"Bridge Pathology Ltd., Bristol, BS7 0BJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloren\ufffd","family":"Grau\u2011Roma","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, LE12 5RD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, LE12 5RD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Boorjian","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gardner","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, LE12 5RD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Mongan","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, LE12 5RD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2018,5,30]]},"reference":[{"key":"key20200714083017_b1-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"key20200714083017_b2-ol-0-0-8837","volume-title":"GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC cancer base no. 11 [Internet]","author":"Ferlay","year":"2013"},{"key":"key20200714083017_b3-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"57766","DOI":"10.18632\/oncotarget.17714","article-title":"Insights from animal models of bladder cancer: Recent advances, challenges, and opportunities","volume":"8","author":"John","year":"2017","journal-title":"Oncotarget"},{"key":"key20200714083017_b4-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrc3858","article-title":"Modelling bladder cancer in mice: Opportunities and challenges","volume":"15","author":"Kobayashi","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"key20200714083017_b5-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3892\/etm.2014.1837","article-title":"Current animal models of bladder cancer: Awareness of translatability (Review)","volume":"8","author":"Ding","year":"2014","journal-title":"Exp Ther Med"},{"key":"key20200714083017_b6-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S1078-1439(99)00006-X","article-title":"Naturally-occurring canine transitional cell carcinoma of the urinary bladder A relevant model of human invasive bladder cancer","volume":"5","author":"Knapp","year":"2000","journal-title":"Urol Oncol"},{"key":"key20200714083017_b7-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/vru.12339","article-title":"Tolerability and tumor response of a novel low-dose palliative radiation therapy protocol in dogs with transitional cell carcinoma of the bladder and urethra","volume":"57","author":"Choy","year":"2016","journal-title":"Vet Radiol Ultrasound"},{"key":"key20200714083017_b8-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3233\/BLC-150044","article-title":"A nonselective cyclooxygenase inhibitor enhances the activity of vinblastine in a naturally-occurring canine model of invasive urothelial carcinoma","volume":"2","author":"Knapp","year":"2016","journal-title":"Bladder Cancer"},{"key":"key20200714083017_b9-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/j.1939-1676.2011.00796.x","article-title":"Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder","volume":"25","author":"Arnold","year":"2011","journal-title":"J Vet Intern Med"},{"key":"key20200714083017_b10-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/j.1939-1676.2010.0569.x","article-title":"Phase I clinical trial and pharmacokinetics of intravesical mitomycin C in dogs with localized transitional cell carcinoma of the urinary bladder","volume":"24","author":"Abbo","year":"2010","journal-title":"J Vet Intern Med"},{"key":"key20200714083017_b11-ol-0-0-8837","first-page":"906","article-title":"Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma","volume":"9","author":"Henry","year":"2003","journal-title":"Clin Cancer Res"},{"key":"key20200714083017_b12-ol-0-0-8837","first-page":"77","article-title":"Tumours of the urinary tract","volume-title":"WHO Classification of Tumours of the Urinary System and Male Genital Organs","author":"Moch","year":"2016","edition":"4th edition"},{"key":"key20200714083017_b13-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"key":"key20200714083017_b14-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/ilar\/ilu018","article-title":"Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development","volume":"55","author":"Knapp","year":"2014","journal-title":"ILAR J"},{"key":"key20200714083017_b15-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0021-9975(05)80027-1","article-title":"Pathology of canine bladder and urethral cancer and correlation with tumour progression and survival","volume":"113","author":"Valli","year":"1995","journal-title":"J Comp Pathol"},{"key":"key20200714083017_b16-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jcpa.2006.07.002","article-title":"Classification of canine urinary bladder urothelial tumours based on the World Health Organization\/International Society of Urological Pathology consensus classification","volume":"135","author":"Patrick","year":"2006","journal-title":"J Comp Pathol"},{"key":"key20200714083017_b17-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1939-1676.1992.tb00330.x","article-title":"Canine bladder and urethral tumors: A retrospective study of 115 cases (1980\u20131985)","volume":"6","author":"Norris","year":"1992","journal-title":"J Vet Intern Med"},{"key":"key20200714083017_b18-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10577-015-9471-y","article-title":"Canine urothelial carcinoma: Genomically aberrant and comparatively relevant","volume":"23","author":"Shapiro","year":"2015","journal-title":"Chromosome Res"},{"key":"key20200714083017_b19-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"e0136688","DOI":"10.1371\/journal.pone.0136688","article-title":"Comparative gene expression analyses identify luminal and basal subtypes of canine invasive urothelial carcinoma that mimic patterns in human invasive bladder cancer","volume":"10","author":"Dhawan","year":"2015","journal-title":"PLoS One"},{"key":"key20200714083017_b20-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1158\/1541-7786.MCR-14-0689","article-title":"Homologous mutation to human BRAF V600E is common in naturally occurring canine bladder cancer-evidence for a relevant model system and urine-based diagnostic test","volume":"13","author":"Decker","year":"2015","journal-title":"Mol Cancer Res"},{"key":"key20200714083017_b21-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"B171","DOI":"10.1093\/gerona\/52A.3.B171","article-title":"Comparative longevity of pet dogs and humans: Implications for gerontology research","volume":"52","author":"Patronek","year":"1997","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"key20200714083017_b22-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ejca.2010.10.007","article-title":"Parity, early menopause and the incidence of bladder cancer in women: A case-control study and meta-analysis","volume":"47","author":"Dietrich","year":"2011","journal-title":"Eur J Cancer"},{"key":"key20200714083017_b23-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/ijc.22418","article-title":"Reproductive risk factors for incident bladder cancer: Iowa Women's Health Study","volume":"120","author":"Prizment","year":"2007","journal-title":"Int J Cancer"},{"key":"key20200714083017_b24-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3892\/or.2013.2416","article-title":"Estrogen receptor-\u03b2 expression and pharmacological targeting in bladder cancer","volume":"30","author":"Kauffman","year":"2013","journal-title":"Oncol Rep"},{"key":"key20200714083017_b25-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1111\/j.1464-410X.2011.10706.x","article-title":"Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder","volume":"109","author":"Miyamoto","year":"2012","journal-title":"BJU Int"},{"key":"key20200714083017_b26-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.urolonc.2009.01.033","article-title":"Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: A comparative analysis of clinicopathological features and survival outcomes according to receptor expression","volume":"29","author":"Tuygun","year":"2011","journal-title":"Urol Oncol"},{"key":"key20200714083017_b27-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1002\/cncr.21945","article-title":"Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue","volume":"106","author":"Shen","year":"2006","journal-title":"Cancer"},{"key":"key20200714083017_b28-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.urology.2004.03.025","article-title":"Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer","volume":"64","author":"Boorjian","year":"2004","journal-title":"Urology"},{"key":"key20200714083017_b29-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1177\/1066896915591271","article-title":"Bladder neck urothelial carcinoma: A urinary bladder subsite carcinoma with distinct clinicopathology","volume":"23","author":"Xiao","year":"2015","journal-title":"Int J Surg Pathol"},{"key":"key20200714083017_b30-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1442-2042.2004.00834.x","article-title":"Histopathological aspects of transitional cell carcinoma of the bladder: Analysis of 20 years experience","volume":"11","author":"Sciarra","year":"2004","journal-title":"Int J Urol"},{"key":"key20200714083017_b31-ol-0-0-8837","first-page":"1630","article-title":"Analysis of bladder carcinoma by subsite","volume":"66","author":"Stephenson","year":"1990","journal-title":"Cystoscopic location may have prognostic value. Cancer"},{"key":"key20200714083017_b32-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.tvjl.2015.01.017","article-title":"Management of transitional cell carcinoma of the urinary bladder in dogs: A review","volume":"205","author":"Fulkerson","year":"2015","journal-title":"Vet J"},{"key":"key20200714083017_b33-ol-0-0-8837","first-page":"107","article-title":"The pathology of urinary bladder lesions with an inverted growth pattern","volume":"28","author":"Guo","year":"2016","journal-title":"Chin J Cancer Res"},{"issue":"Suppl 2","key":"key20200714083017_b34-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1038\/modpathol.2009.26","article-title":"Histological variants of urothelial carcinoma: Diagnostic, therapeutic and prognostic implications","volume":"22","author":"Amin","year":"2009","journal-title":"Mod Pathol"},{"key":"key20200714083017_b35-ol-0-0-8837","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.5858\/2007-131-1244-HVOIUC","article-title":"Histologic variants of infiltrating urothelial carcinoma","volume":"131","author":"Zhai","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"key20200714083017_b36-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S1078-1439(03)00139-X","article-title":"Gender, racial and age differences in bladder cancer incidence and mortality","volume":"22","author":"Madeb","year":"2004","journal-title":"Urol Oncol"},{"key":"key20200714083017_b37-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.urology.2011.02.042","article-title":"Ethnic differences in bladder cancer survival","volume":"78","author":"Yee","year":"2011","journal-title":"Urology"},{"key":"key20200714083017_b38-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.juro.2006.04.074","article-title":"Racial disparity in bladder cancer: Trends in tumor presentation at diagnosis","volume":"176","author":"Lee","year":"2006","journal-title":"J Urol"},{"key":"key20200714083017_b39-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0021-9681(87)90097-X","article-title":"Black\/white differences in bladder cancer patient survival","volume":"40","author":"Hankey","year":"1987","journal-title":"J Chronic Dis"},{"key":"key20200714083017_b40-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/bju.12496","article-title":"Investigation of poorer bladder cancer survival in women in NSW, Australia: A data linkage study","volume":"113","author":"Tracey","year":"2014","journal-title":"BJU Int"},{"key":"key20200714083017_b41-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/aje\/kwj028","article-title":"Hormonal and reproductive factors and the risk of bladder cancer in women","volume":"163","author":"McGrath","year":"2006","journal-title":"Am J Epidemiol"},{"key":"key20200714083017_b42-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.humpath.2017.04.018","article-title":"Urothelial carcinoma involving the ureteral orifice: A clinicopathologic analysis of 93 cases","volume":"65","author":"Annan","year":"2017","journal-title":"Hum Pathol"},{"key":"key20200714083017_b43-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.urology.2016.09.042","article-title":"Outcomes and prognostic factors of primary urethral cancer","volume":"100","author":"Sui","year":"2017","journal-title":"Urology"},{"key":"key20200714083017_b44-ol-0-0-8837","volume-title":"Uropathology: Elsevier Saunders 1st Edition","author":"Zhou","year":"2012"},{"key":"key20200714083017_b45-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/bju.12630","article-title":"Management of advanced primary urethral carcinomas","volume":"114","author":"Dayyani","year":"2014","journal-title":"BJU Int"},{"key":"key20200714083017_b46-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.eururo.2013.03.044","article-title":"EAU guidelines on primary urethral carcinoma","volume":"64","author":"Gakis","year":"2013","journal-title":"Eur Urol"},{"key":"key20200714083017_b47-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.urology.2014.05.011","article-title":"Intravesical tumor involvement of the trigone is associated with nodal metastasis in patients undergoing radical cystectomy","volume":"84","author":"Svatek","year":"2014","journal-title":"Urology"},{"key":"key20200714083017_b48-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"38.e29","DOI":"10.1016\/j.urolonc.2013.04.001","article-title":"Impact of bladder neck involvement on progression in patients with primary non-muscle invasive bladder cancer: A prospective validation study","volume":"32","author":"Kobayashi","year":"2014","journal-title":"Urol Oncol"},{"key":"key20200714083017_b49-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s12032-010-9609-x","article-title":"Urethral carcinoma: Critical view on contemporary consecutive series","volume":"28","author":"Reis","year":"2011","journal-title":"Med Oncol"},{"key":"key20200714083017_b50-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.urology.2006.08.1057","article-title":"Incidence of primary urethral carcinoma in the United States","volume":"68","author":"Swartz","year":"2006","journal-title":"Urology"},{"key":"key20200714083017_b51-ol-0-0-8837","first-page":"766","article-title":"Inverted variant of urothelial carcinoma of the urinary bladder: A report of three cases and a proposal for a new clinicopathologic entity","volume":"6","author":"Terada","year":"2013","journal-title":"Int J Clin Ex Pathol"},{"key":"key20200714083017_b52-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1002\/1097-0142(19840301)53:5<1185::AID-CNCR2820530526>3.0.CO;2-R","article-title":"The grade and pathologic stage of bladder cancer","volume":"53","author":"Kern","year":"1984","journal-title":"Cancer"},{"key":"key20200714083017_b53-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2013","volume":"64","author":"Babjuk","year":"2013","journal-title":"Eur Urol"},{"key":"key20200714083017_b54-ol-0-0-8837","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S0090-4295(00)00523-9","article-title":"Gender differences in stage-adjusted bladder cancer survival","volume":"55","author":"Mungan","year":"2000","journal-title":"Urology"},{"key":"key20200714083017_b55-ol-0-0-8837","volume-title":"Genitourinary diagnostic pathology","author":"Amin","year":"2016","edition":"IInd Edition"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T13:54:21Z","timestamp":1661349261000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2018.8837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,30]]},"references-count":55,"URL":"https:\/\/doi.org\/10.3892\/ol.2018.8837","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,30]]}}}